ONZETRA XSAIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Onzetra Xsail, and what generic alternatives are available?
Onzetra Xsail is a drug marketed by Currax and is included in one NDA. There are seventeen patents protecting this drug.
This drug has two hundred and seventy-one patent family members in twenty-nine countries.
The generic ingredient in ONZETRA XSAIL is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Onzetra Xsail
A generic version of ONZETRA XSAIL was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.
Summary for ONZETRA XSAIL
International Patents: | 271 |
US Patents: | 17 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 60 |
Clinical Trials: | 1 |
Patent Applications: | 4,139 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ONZETRA XSAIL |
What excipients (inactive ingredients) are in ONZETRA XSAIL? | ONZETRA XSAIL excipients list |
DailyMed Link: | ONZETRA XSAIL at DailyMed |


Recent Clinical Trials for ONZETRA XSAIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Avanir Pharmaceuticals | Phase 3 |
Currax Pharmaceuticals | Phase 3 |
Pharmacology for ONZETRA XSAIL
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for ONZETRA XSAIL
US Patents and Regulatory Information for ONZETRA XSAIL
ONZETRA XSAIL is protected by twenty-three US patents.
Patents protecting ONZETRA XSAIL
Nasal delivery devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal delivery devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DELIVERING SUMATRIPTAN TO A NASAL CAVITY
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery method
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF DRUG DELIVERY VIA THE NASAL CAVITY
Powder delivery devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery devices
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal delivery device
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF MIGRAINE VIA DELIVERY OF SUMATRIPTAN VIA THE NASAL CAVITY
Nasal administration
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ACUTE TREATMENT OF MIGRAINE BY DELIVERING A POWDERED SUBSTANCE COMPRISING SUMATRIPTAN VIA A BREATH-POWERED DELIVERY DEVICE
Expired US Patents for ONZETRA XSAIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | See Plans and Pricing | See Plans and Pricing |
Currax | ONZETRA XSAIL | sumatriptan succinate | POWDER;NASAL | 206099-001 | Jan 27, 2016 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ONZETRA XSAIL
See the table below for patents covering ONZETRA XSAIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | 2008513078 | See Plans and Pricing | |
Norway | 20071661 | See Plans and Pricing | |
United Kingdom | 2390813 | Nasal devices | See Plans and Pricing |
Japan | 5561902 | See Plans and Pricing | |
Japan | 4959906 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |